一项关于他克莫司和胸腺球蛋白作为相关供者异基因造血细胞移植中移植物抗宿主病预防的 II 期研究。
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
机构信息
Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan.
Department of Hematology and Medical Oncology, Winship Cancer Center and Emory University, Atlanta, Georgia.
出版信息
Am J Hematol. 2018 Aug;93(4):E96-E98. doi: 10.1002/ajh.25035. Epub 2018 Feb 5.
Abstract
NCT01246206. The study was approved by Wayne State University Institutional Review Board.
摘要
NCT01246206. 该研究已获得韦恩州立大学机构审查委员会的批准。
相似文献
1
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.一项关于他克莫司和胸腺球蛋白作为相关供者异基因造血细胞移植中移植物抗宿主病预防的 II 期研究。
Am J Hematol. 2018 Aug;93(4):E96-E98. doi: 10.1002/ajh.25035. Epub 2018 Feb 5.
2
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.西罗莫司和他克莫司联合抗胸腺细胞球蛋白预防可降低异基因造血干细胞移植后急性移植物抗宿主病的风险，但无总体生存获益。
Biol Blood Marrow Transplant. 2011 Jun;17(6):916-22. doi: 10.1016/j.bbmt.2010.09.017. Epub 2010 Dec 4.
3
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience.西罗莫司、他克莫司和抗胸腺细胞球蛋白在HLA配型不合的无关供者造血细胞移植中预防移植物抗宿主病：单中心经验
Bone Marrow Transplant. 2015 Nov;50(11):1487-9. doi: 10.1038/bmt.2015.192. Epub 2015 Aug 24.
4
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.一项双臂2期临床试验的结果，该试验使用移植后环磷酰胺预防单倍体相合供者和错配无关供者造血干细胞移植中的移植物抗宿主病。
Cancer. 2016 Nov 15;122(21):3316-3326. doi: 10.1002/cncr.30180. Epub 2016 Jul 12.
5
Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.异基因干细胞移植后免疫重建的动态系统建模可识别出有不良结局风险的患者。
Biol Blood Marrow Transplant. 2015 Jul;21(7):1237-45. doi: 10.1016/j.bbmt.2015.03.011. Epub 2015 Apr 4.
6
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study.减低预处理强度异基因移植后使用他克莫司联合西罗莫司预防移植物抗宿主病：一项多中心研究结果
Bone Marrow Transplant. 2016 Nov;51(11):1524-1526. doi: 10.1038/bmt.2016.163. Epub 2016 Jun 13.
7
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation.一项评价他克莫司联合西罗莫司或甲氨蝶呤用于异基因造血细胞移植后的随机 II 期研究。
Haematologica. 2012 Dec;97(12):1882-9. doi: 10.3324/haematol.2012.067140. Epub 2012 Jun 11.
8
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years.抗胸腺细胞球蛋白（兔）与抗胸腺细胞球蛋白（费森尤斯）用于预防单倍体相合异基因造血干细胞移植后移植物抗宿主病的比较研究：近年来单中心经验
Leuk Lymphoma. 2018 Nov;59(11):2700-2705. doi: 10.1080/10428194.2018.1439584. Epub 2018 Mar 12.
9
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.两种不同剂量兔抗淋巴细胞球蛋白预防亲缘供者异基因造血干细胞移植后儿童移植物抗宿主病的疗效：一项多中心、随机、开放标签、3 期临床试验。
Lancet Oncol. 2017 Aug;18(8):1126-1136. doi: 10.1016/S1470-2045(17)30417-5. Epub 2017 Jul 10.
10
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.全身电子束照射与非清髓性异基因造血干细胞移植治疗晚期蕈样霉菌病和 Sezary 综合征。
J Clin Oncol. 2010 May 10;28(14):2365-72. doi: 10.1200/JCO.2009.25.8301. Epub 2010 Mar 29.
本文引用的文献
1
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial.接受匹配相关供者异基因干细胞移植的老年患者非复发死亡率低且长期生活质量得以保持：一项前瞻性多中心II期试验
Haematologica. 2015 Feb;100(2):269-74. doi: 10.3324/haematol.2014.113571. Epub 2014 Nov 25.
2
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.抗胸腺细胞球蛋白（胸腺球蛋白）、他克莫司和西罗莫司作为异基因造血干细胞移植的急性移植物抗宿主病预防药物。
Biol Blood Marrow Transplant. 2012 Nov;18(11):1734-44. doi: 10.1016/j.bbmt.2012.06.004. Epub 2012 Jun 16.
3
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.抗 T 细胞抗体的免疫调节对血液系统恶性肿瘤患者接受低强度异基因造血干细胞移植结局的影响。
Blood. 2011 Jun 23;117(25):6963-70. doi: 10.1182/blood-2011-01-332007. Epub 2011 Apr 4.
4
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.异基因造血干细胞移植后的粘膜炎：一项关于含甲氨蝶呤和不含甲氨蝶呤的移植物抗宿主病预防方案的队列研究。
Biol Blood Marrow Transplant. 2005 May;11(5):383-8. doi: 10.1016/j.bbmt.2005.02.006.
5
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.在匹配的相关供体外周血干细胞移植后，使用西罗莫司和他克莫司且不使用甲氨蝶呤作为移植物抗宿主病的预防措施。
Biol Blood Marrow Transplant. 2004 May;10(5):328-36. doi: 10.1016/j.bbmt.2003.12.305.
6
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.一项III期研究，比较甲氨蝶呤与他克莫司（普乐可复，FK506）联合甲氨蝶呤与环孢素用于HLA匹配同胞骨髓移植后预防移植物抗宿主病的效果。
Blood. 1998 Oct 1;92(7):2303-14.
Zotero 插件